THC * Stock Overview
Operates as a diversified healthcare services company in the United States.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Tenet Healthcare Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$3,300.00 |
52 Week High | US$3,300.00 |
52 Week Low | US$1,140.66 |
Beta | 2.15 |
11 Month Change | 9.98% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 201.02% |
Recent News & Updates
Recent updates
Shareholder Returns
THC * | MX Healthcare | MX Market | |
---|---|---|---|
7D | 10.0% | -3.1% | -0.3% |
1Y | n/a | -14.0% | -1.8% |
Return vs Industry: Insufficient data to determine how THC * performed against the MX Healthcare industry.
Return vs Market: Insufficient data to determine how THC * performed against the MX Market.
Price Volatility
THC * volatility | |
---|---|
THC * Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.3% |
Market Average Movement | 4.0% |
10% most volatile stocks in MX Market | 6.2% |
10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: THC *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine THC *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 92,655 | Saum Sutaria | www.tenethealth.com |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Tenet Healthcare Corporation Fundamentals Summary
THC * fundamental statistics | |
---|---|
Market cap | Mex$323.92b |
Earnings (TTM) | Mex$63.82b |
Revenue (TTM) | Mex$428.14b |
5.1x
P/E Ratio0.8x
P/S RatioIs THC * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
THC * income statement (TTM) | |
---|---|
Revenue | US$20.97b |
Cost of Revenue | US$12.68b |
Gross Profit | US$8.29b |
Other Expenses | US$5.17b |
Earnings | US$3.13b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 32.87 |
Gross Margin | 39.55% |
Net Profit Margin | 14.91% |
Debt/Equity Ratio | 155.6% |
How did THC * perform over the long term?
See historical performance and comparison